We have criticised the Scottish Medicines Consortium's (SMC) decision not to recommend abiraterone for use on the NHS in Scotland. It follows the National Institute for Health and Clinical Excellence's (NICE) draft decision to deny the drug for men on the NHS in England and Wales.

Read more

Research into prostate cancer receives a major boost today (24th January) as The Prostate Cancer Charity announces its largest research investment into the disease to date.

Researchers from the Universities of Glasgow and Aberdeen will lead on three of the 15 projects from across the UK to be funded by The Prostate Cancer Charity. The Charity is investing over £2 million in an attempt to target some of the most important research challenges facing prostate cancer, from helping to diagnose the disease through to improving treatment options and quality of life for men living with it.

Read more